Clinical Trial: Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Randomised, Double-blind, Placebo-controlled Trial of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
Brief Summary: The aim of this study is to evaluate the clinical efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections in China.
Detailed Summary:
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Current Primary Outcome: Time to alleviation of clinically important symptoms [ Time Frame: up to 21 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Symptom score AUC [ Time Frame: 6 days ]
- Mean symptom scores [ Time Frame: 6 days ]
- The use of relief medication [ Time Frame: 6 days ]
Original Secondary Outcome: Same as current
Information By: Jiangsu Simcere Pharmaceutical Co., Ltd.
Dates:
Date Received: October 21, 2011
Date Started: October 2011
Date Completion:
Last Updated: January 15, 2013
Last Verified: January 2013
